Shumei Liu

机构：Capital Medical University · ORCID：0000-0001-5262-0015

发表论文 81 篇 · 总被引 4345 次 · h-index 23

代表论文

• Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer (2020 · Journal of Medicinal Chemistry · 被引 224)
• 6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors (2019 · Journal of Medicinal Chemistry · 被引 86)
• Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors (2019 · Journal of Medicinal Chemistry · 被引 85)
• Role of the thioredoxin interacting protein in diabetic nephropathy and the mechanism of regulating NOD‑like receptor protein 3 inflammatory corpuscle (2019 · International Journal of Molecular Medicine · 被引 46)
• LIMD1‐AS1 suppressed non‐small cell lung cancer progression through stabilizing LIMD1 mRNA via hnRNP U (2020 · Cancer Medicine · 被引 24)
• Deficiency of Tlr7 and Irf7 in mice increases the severity of COVID-19 through the reduced interferon production (2024 · Communications Biology · 被引 21)